» Articles » PMID: 27608759

Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2016 Sep 10
PMID 27608759
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphatic vasculature drains interstitial fluids, which contain the tissue's waste products, and ensures immune surveillance of the tissues, allowing immune cell recirculation. Until recently, the CNS was considered to be devoid of a conventional lymphatic vasculature. The recent discovery in the meninges of a lymphatic network that drains the CNS calls into question classic models for the drainage of macromolecules and immune cells from the CNS. In the context of neurological disorders, the presence of a lymphatic system draining the CNS potentially offers a new player and a new avenue for therapy. In this review, we will attempt to integrate the known primary functions of the tissue lymphatic vasculature that exists in peripheral organs with the proposed function of meningeal lymphatic vessels in neurological disorders, specifically multiple sclerosis and Alzheimer's disease. We propose that these (and potentially other) neurological afflictions can be viewed as diseases with a neuro-lympho-vascular component and should be therapeutically targeted as such.

Citing Articles

Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing.

Xu Y, Bai X, Lin J, Lu K, Weng S, Wu Y Mol Ther Methods Clin Dev. 2025; 33(1):101420.

PMID: 40034424 PMC: 11874542. DOI: 10.1016/j.omtm.2025.101420.


Near-Infrared Imaging of Glymphatic Clearance in a Pre-Clinical Model of Repetitive Closed Head Traumatic Brain Injury.

Michalaki E, Pulliam A, Datta Roy P, Dixon J, LaPlaca M Neurotrauma Rep. 2025; 6(1):115-128.

PMID: 39990707 PMC: 11839536. DOI: 10.1089/neur.2024.0128.


Glymphatic system in neurological disorders and implications for brain health.

Corbali O, Levey A Front Neurol. 2025; 16:1543725.

PMID: 39974364 PMC: 11835678. DOI: 10.3389/fneur.2025.1543725.


A Window into New Insights on Progression Independent of Relapse Activity in Multiple Sclerosis: Role of Therapies and Current Perspective.

Guerra T, Iaffaldano P Int J Mol Sci. 2025; 26(3).

PMID: 39940654 PMC: 11817336. DOI: 10.3390/ijms26030884.


Cranial bone maneuver ameliorates Alzheimer's disease pathology via enhancing meningeal lymphatic drainage function.

Lu X, Bai S, Feng L, Yan X, Lin Y, Huang J Alzheimers Dement. 2025; 21(2):e14518.

PMID: 39887820 PMC: 11848205. DOI: 10.1002/alz.14518.


References
1.
Wu J, Breydo L, Isas J, Lee J, Kuznetsov Y, Langen R . Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J Biol Chem. 2009; 285(9):6071-9. PMC: 2825401. DOI: 10.1074/jbc.M109.069542. View

2.
Naj A, Jun G, Beecham G, Wang L, Vardarajan B, Buros J . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5):436-41. PMC: 3090745. DOI: 10.1038/ng.801. View

3.
Goodin D . The epidemiology of multiple sclerosis: insights to disease pathogenesis. Handb Clin Neurol. 2014; 122:231-66. DOI: 10.1016/B978-0-444-52001-2.00010-8. View

4.
Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif A, Spinrad A . Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat Commun. 2015; 6:7967. PMC: 4557123. DOI: 10.1038/ncomms8967. View

5.
Rennels M, Blaumanis O, Grady P . Rapid solute transport throughout the brain via paravascular fluid pathways. Adv Neurol. 1990; 52:431-9. View